Business
China makes steady progress on COVID-19 drug R&D; Pfizer’s oral antiviral therapy ‘maybe difficult to get’ – Global Times
Chinese firms are making steady progress on the research and development (R&D) of COVID-19 drugs and, once put into use, they…
A child at an elementary school in Haikou, South China’s Hainan Province receives a COVID-19 vaccine on October 26, 2021. Photo: VCG
Chinese firms are making steady progress on the research and development (R&D) of COVID-19 drugs and, once put into use,…
Continue Reading